Ultrasound Diagnosis of Hepatocellular Carcinoma: Is the Future Defined by Artificial Intelligence?

Maximilian J. Waldner; Deike Strobel

doi:10.1055/a-2171-2674

Ultraschall in der Medizin - European Journal of Ultrasound, Inhaltsverzeichnis

Ultraschall Med 2024; 45(01): 8-12
DOI: 10.1055/a-2171-2674

Editorial

Ultraschalldiagnostik des hepatozellulären Karzinoms: In Zukunft nur mit künstlicher Intelligenz?

Artikel in mehreren Sprachen: English | deutsch

Maximilian J. Waldner

Medical Clinic 1, Erlangen University Hospital, Erlangen, Germany

,

Deike Strobel

Medical Clinic 1, Erlangen University Hospital, Erlangen, Germany

References
1 Haug CJ, Drazen JM. Artificial Intelligence and Machine Learning in Clinical Medicine. N Engl J Med 2023; 388 (13) 1201-1208
2 Streim A, Beerlink KP. Drei Viertel sehen Künstliche Intelligenz als Chance. Presseinformation [Web Page] 2023 [cited 2023 11/12/2023]; Available from:. https://www.bitkom.org/Presse/Presseinformation/Drei-Viertel-sehen-Kuenstliche-Intelligenz-Chance
3 Kim M, Yun J, Cho Y. et al. Deep Learning in Medical Imaging. Neurospine 2019; 16 (04) 657-668
4 Koh DM, Papanikolaou N, Bick U. et al. Artificial intelligence and machine learning in cancer imaging. Commun Med (Lond) 2022; 2: 133
5 El Naqa I, Haider MA, Giger ML. et al. Artificial Intelligence: reshaping the practice of radiological sciences in the 21st century. Br J Radiol 2020; 93: 20190855
6 Park SH. Artificial intelligence for ultrasonography: unique opportunities and challenges. Ultrasonography 2021; 40 (01) 3-6
7 Rinella ME, Lazarus JV, Ratziu V. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol 2023; 29 (01) 101133
8 Gross S, Bitzer M, Blodt S. et al. Leitlinienreport der S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms und biliärer Karzinome – Version 3.0 – Juli 2022, AWMF-Registernummer: 032/053OL. Z Gastroenterol 2023; 61 (04) e157-e171
9 European Association for the Study of the Liver. Electronic address, e.e.e. and L. European Association for the Study of the, EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69 (01) 182-236
10 Dietrich CF, Teufel A, Sirlin CB. et al. Surveillance of hepatocellular carcinoma by medical imaging. Quant Imaging Med Surg 2019; 9 (11) 1904-1910
11 Tiyarattanachai T, Apiparakoon T, Marukatat S. et al. Development and validation of artificial intelligence to detect and diagnose liver lesions from ultrasound images. PLoS One 2021; 16 (06) e0252882
12 Yang Q, Wei J, Hao X. et al. Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: A multicentre study. EBioMedicine 2020; 56: 102777
13 Strobel D. Using contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma – what we have and have not achieved. Ultraschall in Med 2021; 42 (02) 120-124
14 Schellhaas B, Bernatik T, Dirks K. et al. Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation. Ultrasound Med Biol 2021; 47 (11) 3170-3180
15 Schellhaas B, Bernatik T, Bohle W. et al. Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma – A Prospective Multicenter DEGUM Study. Ultraschall in Med 2021; 42 (02) 178-186
16 Vetter M, Waldner MJ, Zundler S. et al. Artificial intelligence for the classification of focal liver lesions in ultrasound – a systematic review. Ultraschall in Med 2023;
17 Kuang M, Hu HT, Li W. et al. Articles That Use Artificial Intelligence for Ultrasound: A Readerʼs Guide. Front Oncol 2021; 11: 631813